![Mark Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Finn
Président chez
CALYXTPAR
Fortune : 2 M $ au 31/05/2026
Profil
Mark Terrence Finn is the founder of NEW Ventures LLC, New Ventures Select LLC.
Current positions include Chairman, CEO & CCO at Vantage Consulting Group, Inc. since 1986; Chairman at Cibus, Inc. starting 2025; Director at Cibus Corp.
since 2009; Director at Cibus US LLC; Director at Cibus Ltd.; Director at Enterin, Inc. since 2017; Managing Member at New Ventures I LLC, New Ventures II LLC, and New Ventures III LLC.
Former positions include Director at The RF&P Corp.; Principal at Lindner Asset Management, Inc. from 1999 to 2001; Professor at the University of Virginia; Principal at Virginia National Bank (Charlottesville).
Education includes an MBA from The College of William & Mary, conferred in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CIBUS, INC. CLASS A 2,38 % | 02/06/2026 | 1 247 962 ( 2,38 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Mark Finn
| Sociétés | Poste | Début |
|---|---|---|
| CALYXT, INC. | Directeur/Membre du Conseil | 01/01/2009 |
| CALYXTPAR | Président | 06/08/2025 |
Cibus US LLC
 Cibus US LLC BiotechnologyHealth Technology Develops products in agriculture and specialty chemicals | Directeur/Membre du Conseil | - |
Cibus Ltd.
 Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Directeur/Membre du Conseil | - |
Vantage Consulting Group, Inc.
 Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Directeur Général | 01/01/1986 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Directeur/Membre du Conseil | 01/01/2017 |
New Ventures I LLC
 New Ventures I LLC Investment ManagersFinance Functions as a venture capital fund | Corporate Officer/Principal | - |
New Ventures III LLC
 New Ventures III LLC Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
New Ventures II LLC
 New Ventures II LLC Investment ManagersFinance Functions as a venture capital fund | Corporate Officer/Principal | - |
Anciens postes connus de Mark Finn
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Mark Finn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Lindner Asset Management, Inc.
 Lindner Asset Management, Inc. Investment ManagersFinance Lindner is a mid/large-cap growth manager of managers. Their approach is to offer a diversified family of products through the selection of the optimum manager in each investment strategy. They continually monitor the adherence of the sub-advisors to their prescribed investment criteria. Lindner's ongoing monitoring of the sub-advisors includes tracking of style, performance and risk measurement to the appropriate benchmark and peer group. | Finance |
NEW Ventures LLC
 NEW Ventures LLC Information Technology ServicesTechnology Services Provides information technology services for health industry | Technology Services |
New Ventures I LLC
New Ventures I LLC Investment ManagersFinance Functions as a venture capital fund | Finance |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
New Ventures Select LLC
 New Ventures Select LLC Investment ManagersFinance Functions as a venture capital fund | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia National Bank (Charlottesville)
 Virginia National Bank (Charlottesville) Major BanksFinance Operates as a national chartered bank | Finance |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The RF&P Corp.
 The RF&P Corp. Other Consumer ServicesConsumer Services Provides railroad transportation services | Consumer Services |
Cibus US LLC
Cibus US LLC BiotechnologyHealth Technology Develops products in agriculture and specialty chemicals | Health Technology |
Cibus, Inc.
 Cibus, Inc. Information Technology ServicesTechnology Services Operates as an agricultural technology company | Technology Services |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Engages in the research and development of plant gene editing technology | Health Technology |
Vantage Consulting Group, Inc.
Vantage Consulting Group, Inc. Investment ManagersFinance Vantage strives to deliver a comprehensive, bespoke investment solution firmly grounded in fundamental investment principles. At the core of this solution lies an investment strategy meticulously tailored to their clients’ unique investment objectives, risk tolerances, diversification preferences, and their specific liquidity needs and investment horizons. | Finance |
New Ventures III LLC
New Ventures III LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Health Technology |
New Ventures II LLC
New Ventures II LLC Investment ManagersFinance Functions as a venture capital fund | Finance |
